Persistence of antihypertensive efficacy after missed doses: Comparison of amlodipine and nifedipine gastrointestinal therapeutic system

Journal of Hypertension

Volumn 20, Issue 2, 2002, Pages 333-338

  Elliott, Henry L ^a   Elawad, Mamoun ^a   Wilkinson, Robert ^a   Singh, Shyam P ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Amlodipine; Compliance; Hypertension; Nifedipine gastrointestinal therapeutic system

Indexed keywords

AMLODIPINE; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; FLUSHING; HEADACHE; HOT FLUSH; HUMAN; HYPESTHESIA; MALE; MIGRAINE; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0036464219     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200202000-00025     Document Type: Article

References (20)

1. Therapeutic coverage: Reducing the risks of partial compliance
2. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system: A controlled-release formulation of nifedipine
3. Nifedipine GITS. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris
4. Review of the pharmacology of amlodipine
5. Analysis of amlodipine in human plasma by gas chromatography
6. Pharmacodynamic modelling of the antihypertensive response to amlodipine
7. The first pass metabolism of nifedipine in man
8. Combination of nifedipine and doxazosin in essential hypertension
9. Trough and peak effects of a single dose of nifedipine GITS as assessed by ambulatory blood pressure monitoring
10. A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects
11. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses
12. Persistent antihypertensive effect of amlodipine 3 days after discontinuation of therapy: A prospective double-blind randomisation study
13. Persistence of antihypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) versus short (diltiazem) elimination half-life
14. The effects of missing a dose of enalapril versus amlodipine on ambulatory blood pressure monitoring
15. Therapeutic implications of drug holidays
16. Prognostic value of 24-hour blood pressure variability
17. Blood pressure variability: Clinical implications and effects of antihypertensive treatment
18. Clinical relevance of night-time blood pressure and of daytime blood pressure variability
19. Amlodipine
20. The nifedipine GITS. Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties